Libreview driver for mac5/31/2023 ![]() Additional data show the positive impact of the FreeStyle Libre system and LibreView app in helping healthcare professionals make earlier treatment decisions and detecting hypoglycemic eventsĪBBOTT PARK, Ill., J/ PRNewswire/ - Abbott (NYSE: ABT) today announced late-breaking clinical data that demonstrate the FreeStyle Libre ® 3 system has an overall mean absolute relative difference (MARD) of 7.9%, 1 making it the first and only 14-day continuous glucose monitoring (CGM) system to achieve a sub-8% overall MARD.Data at the American Diabetes Association 82 nd Scientific Sessions show Abbott's FreeStyle Libre 3 system is first and only 14-day continuous glucose monitor (CGM) system to achieve a mean absolute relative difference (MARD) of less than 8%.
0 Comments
Leave a Reply. |